glp-1 news november 5 2025 KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and Use glp-1 news today november 5

[16] While FDA prescribing information for most GLP-1 medications does not list GERD as a primary adverse effect, some labels do mention dyspepsia and occasional reports of GERD symptoms

The glucagon component, in particular, adds effects that semaglutide and tirzepatide users do not experience, including increased thermogenesis and changes in hepatic glucose output

doi: 10.1016/j.jff.2023.105944

Choose injectable GLP-1s if: Maximum weight loss is your primary goal You want proven, consistent results backed by extensive clinical trials Weekly dosing fits better into your routine than daily medication You have absorption issues or take other morning medications Cost is a concern (compounded injectables are most affordable) You value the gold standard with predictable outcomes Consider FDA-approved oral tablets if: You're extremely needle-averse and won't use injections You have modest weight loss goals You can maintain a strict morning medication routine with 30-minute fasting You prefer FDA-approved medications over compounded options You don't mind the lower bioavailability and the need for higher doses Consider compounded ODT formulations if: You're needle-averse but want to avoid swallowing pills You're willing to try an emerging option without clinical validation You can afford the higher cost compared to compounded injectables You're comfortable with daily dosing For most people seeking significant weight loss, injectable GLP-1 medications currently offer superior results, better convenience (despite being injections), and more cost-effective options through oral options